Targeted cd1d molecules

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/00 (2006.01) A61K 39/385 (2006.01) A61K 39/44 (2006.01) C07K 14/74 (2006.01) C07K 16/28 (2006.01) C07K 16/30 (2006.01)

Patent

CA 2502735

The invention is directed to a compound comprising one or more CD1d complexes in association with an antibody specific for a cell surface marker. The CD1d complexes comprise a CD1d, a .szlig.2-microglobulin molecule, and may further comprise an antigen bound to the CD1d binding groove. The invention is further directed to methods of inhibiting or stimulating an immune response with the CD1d-antibody compounds, in particular anti-tumor and autoimmunity responses.

L'invention concerne un composé renfermant un ou plusieurs complexes CD1d associés à un anticorps spécifique d'un marqueur de surface cellulaire. Les complexes CD1d comprennent un CD1d, une molécule de .szlig.2-microglobuline, et, éventuellement, un antigène lié au sillon de liaison de CD1d. Cette invention concerne également des méthodes propres à inhiber ou à stimuler une réponse immunitaire au moyen de composés anticorps CD1d, en particulier des réponses anti-tumorales et d'auto-immunité.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Targeted cd1d molecules does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Targeted cd1d molecules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeted cd1d molecules will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1904095

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.